Bengaluru: GLP-1 drugs such as Ozempic and Mounjaro, used for diabetes and obesity, are now being explored for hormonal disorders such as Polycystic Ovary Syndrome
The government has welcomed new guidance to help GPs spot the signs of childhood abdominal cancers sooner.The Child Cancer Smart campaign, led by CCLG: The
India and Norway have reaffirmed their commitment to strengthening bilateral economic ties, with a focus on trade, investment and sectoral cooperation, during the third session
It begins with an Instagram reel: an influencer touting the most potent weight-loss peptides. Two taps, and the feed is flooded with peptide-fuelled weight-loss journeys.
India plans to restrict the testing of vaccines and specialized biological products exclusively to government controlled laboratories to maintain quality standards, according to two government
Kiran Mazumdar-Shaw, Ex-ecutive Chairperson, Biocon Ltd, has flagged structural gaps in India’s biotech eco-system, warning that weak venture funding, regulatory bottlenecks, and the absence of
Eli Lilly has agreed to pay up to $7.8 billion to acquire Centessa Pharmaceuticals and its experimental drug for excessive daytime sleepiness, the company said
The US President Donald J Trump’s proclamation imposing 100% tariff on patented pharmaceuticals and their ingredients may have limited impact on the Indian pharma industry
India could soon get a lot thinner – at least in theory.On Friday the patent on semaglutide – the molecule behind Danish drugmaker Novo Nordisk’s
Hetero launches its generic semaglutide portfolio in international markets, enhancing access to advanced diabetes and obesity therapies. Hetero has launched its generic semaglutide portfolio in
Copyright © 2025 Gubba Cold Storage Ltd, All rights reserved. Designed, Developed by TenJump